drugset / Trial / NCT04375436
Safety and Tolerability of NTRX-07 in Healthy Volunteers
Phase 1
Completed
48 enrolled
NeuroTherapia, Inc.
Integrium · collabOrange County Research Center · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
Randomized, placebo-controlled, modified parallel-design single ascending dose (SAD) in adult healthy volunteers (HVs).
Timeline
- Start
- 2019-10-10
- Primary completion
- 2020-05-15
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NTRX-07-SDD | Unknown | 0.3 mg/kg | Oral |
| Comparator | NTRX-07-SDD | Unknown | 8 mg/kg | Oral |